SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "id:"swepub:oai:prod.swepub.kib.ki.se:138066223" "

Search: id:"swepub:oai:prod.swepub.kib.ki.se:138066223"

  • Result 1-1 of 1
Sort/group result
   
EnumerationReferenceCoverFind
1.
  • Freedman, MS, et al. (author)
  • The efficacy of teriflunomide in patients who received prior disease-modifying treatments: Subgroup analyses of the teriflunomide phase 3 TEMSO and TOWER studies
  • 2018
  • In: Multiple sclerosis (Houndmills, Basingstoke, England). - : SAGE Publications. - 1477-0970 .- 1352-4585. ; 24:4, s. 535-539
  • Journal article (peer-reviewed)abstract
    • Teriflunomide is a once-daily oral immunomodulator approved for relapsing-remitting multiple sclerosis (MS). The objective of this post hoc analysis of the phase 3, pooled TEMSO (NCT00134563) and TOWER (NCT00751881) dataset is to evaluate the effect of teriflunomide treatment on annualised relapse rate and disability worsening across patient subgroups defined according to prior disease-modifying therapy exposure. This analysis provides further supportive evidence for a consistent effect of teriflunomide across a broad range of patients with relapsing MS, including patients who have used and discontinued other disease-modifying therapies.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-1 of 1
Type of publication
journal article (1)
Type of content
peer-reviewed (1)
Author/Editor
Comi, G (1)
Benamor, M (1)
Truffinet, P (1)
Kappos, L (1)
Wolinsky, JS (1)
Olsson, TP (1)
show more...
O'Connor, PW (1)
Freedman, MS (1)
Miller, AE (1)
Thangavelu, K (1)
show less...
University
Karolinska Institutet (1)
Language
English (1)
Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view